The nucleotide sequences of the proximal promoters of UDP-glucuronosyltransferase (UGT) 1A8 and 1A9 genes are very similar. However, UGT1A8 and 1A9 are mainly expressed in extra-hepatic and hepatic cells, respectively. Using mutants of UGT1A8 and 1A9 proximal promoters, we revealed their critical differences in terms of promoter activity and the role of the T-repeat region (T-region) conserved in both promoters. In extra-hepatic cells, Caco2, the activity of UGT1A9 proximal promoter increased to 73.4 « 8.5% of that of the UGT1A8 proximal promoter with only 4 base changes: ¹160C, ¹152A, ¹62T, and ¹59G. The derivatives of the T-region showed that this region is not necessary for promoter activity, but the length of T repeats influences the activity somewhat. Therefore, the cause of the low activity of the UGT1A9 proximal promoter may be not only 4 base changes, but also the truncation of T repeats. From these results, the UGT1A9 proximal promoter was assumed to change into the non-active form from the original sequence, and this might be one of the reasons for the tissue-specific expression of UGT1A9.
Introduction
The UDP glucuronosyltransferase 1 (UGT1) locus contains 13 individual versions of exon 1 (A1 to A13) in addition to shared exons 2-5.
1) Four of the 13 individual versions of exon 1 are pseudogenes, while the remaining nine encode mature proteins (UGT1A1, [3] [4] [5] [6] [7] [8] [9] [10] . Each exon 1 possesses a specific promoter at 5A-UTR and creates an individual RNA molecule. Each UGT1 form has different specificity for the substrate and tissue distribution. UGT1A7, 1A8, and 1A10 are mainly expressed in the gastrointestinal tract, but the other UGT1 forms are found in many tissues including the liver.
2-4)
The UGT1A7-10 genes have high homology and comprise a cluster, 1) and only UGT1A9 is found in the liver. 5) Gregory et al. reported that the promoters of UGT1A8 and 1A10 were activated depending on hepatocyte nuclear factor 1¡ (HNF1¡) and caudalrelated homeodomain protein 2 (Cdx2). 6) On the other hand, the promoter activity of UGT1A9 depends on HNF1¡ and 4¡. [7] [8] [9] [10] HNF4¡ is expressed in the liver, kidney, pancreas, and intestine, and it controls the expression of many metabolizing enzymes in human hepatocytes. 11) However, the regulatory mechanism behind the hepatic and extra-hepatic expression of UGT1A7-10 has yet to be clarified completely.
The nucleotide sequences of 5A-UTR in UGT1A8 and 1A9 genes are very similar within the region about 900 bp from the initiation codon, and the proximal promoters are located within 200 bp. Both promoters contain a conserved T-repeat region (T 14 in UGT1A8 and T 9 or T 10 in UGT1A9), designated the T-region, at the same position. It was previously suggested that the T-region may function as a TATA box 1) ; however, Gregory et al. reported that the activity of the UGT1A8 proximal promoter was not dependent on the T-region. 6) Although the role of the T-region is still unclear, Yamanaka et al. reported that a single nucleotide polymorphism (SNP) in the T-region of UGT1A9 (T 9 or T 10 ) affected the promoter activity. 12) In this study, using mutation derivatives of UGT1A8 and 1A9 proximal promoters, we examined (i) the critical differences between the two in terms of promoter activity, and (ii) the role of the T-region in this activity.
Materials and Methods
Primers and enzymes: The primers used in this study are listed in Supplementary Table S1 . The enzymes were purchased from Invitrogen (Carlsbad, CA) or Nippon Gene Co. (Toyama, Japan), and all reactions were performed as specified by the manufacturers. Plasmids were transformed into Escherichia coli JM109 with CaCl 2 , and the transformants were then selected on LB agar plates containing 50 µg of ampicillin/ml. The DNA was sequenced with an ABI PRISM 310 Genetic Analyzer (Applied Biosystems Japan, Tokyo, Japan).
Cloning of the UGT1A8 and 1A9 proximal promoters: The proximal promoter region of UGT1A8 (¹170/¹5, A of the initiation codon corresponds to a position of +1) was amplified by PCR using the primers 1A8F and 1A8R. One hundred nanograms of human genomic DNA prepared from peripheral blood was used as the template. The amplified DNA was digested with KpnI and HindIII, and cloned into a luciferase reporter vector, pGL3-basic (Promega, Madison, WI). The resulting plasmid was designated pGL1A8. The proximal promoter region of UGT1A9 (¹171/¹5) was amplified using the primers 1A9F and 1A9R. The amplified DNA was cloned into pGL3-basic by the same procedure. The resulting plasmid was designated pGL1A9.
Construction of pGL1A8 derivatives: Plasmids pGL1A8-T 0 to T 20 were constructed by sequentially increasing or decreasing T by 2 nucleotides. Site-directed mutagenesis was performed by the circular mutagenesis method. 13, 14) One microgram of pGL1A8-T x was used as the template, and the primers 1A8T x « 2 F and 1A8T x « 2 R were used for mutagenesis.
The T-region in pGL1A8-T 10 was also changed to a C 10 repeat using the following steps. The PCR products amplified using primers 1A8C 10 F and 1A8R and using 1A8F and 1A8C 10 R were mixed, and the fragment extension was repeated five times under conditions of 95°C for 30 s, 61°C for 30 s, and 72°C for 120 s. The extension product was then amplified using primers 1A8F and 1A8R, and cloned into pGL3-basic. The resulting plasmid was designated pGL1A8-C 10 .
Construction of pGL1A9 derivatives: The sequence upstream of the T-region in pGL1A9 was amplified using the primers 1A9F and 1A9r2R. The sequence downstream of it was also amplified using the primers 1A9R and 1A9r2F. The PCR products (upstream and downstream of the T-region) were mixed, and fragment extension and second PCR using the primers 1A9F and 1A9R were performed as described above. The amplified DNA was cloned into pGL3-basic, and the resulting plasmid was designated pGL1A9-r2. Parts of the UGT1A9 promoter (¹171/¹44) in pGL1A9 and pGL1A9-r2 were amplified using the primers 1A9F and 1A9r3R. Another part of the UGT1A9 promoter (¹82/¹5) in pGL1A9 was also amplified using the primers 1A9R and 1A9r3F. The fragment extension, second PCR, and the cloning were performed by the same procedure. The resulting plasmids were designated pGL1A9-r3 and pGL1A9-r23.
Next, the UGT1A9 promoters (¹157/¹5) in pGL1A9, pGL1A9-r2, pGL1A9-r3, and pGL1A9-r23 were amplified using the primers 1A9r1F and 1A9R. The PCR products were then re-amplified using the primers 1A8F and 1A9R. These fragments were cloned into pGL3-basic, and the resulting plasmids were designated pGL1A9-r1, pGL1A9-r12, pGL1A9-r13, and pGL1A9-r123, respectively. Base substitutions in regions 1 and 3 of pGL1A9 were performed by circular mutagenesis method using the primers shown in Supplementary Table S1 .
Cell culture, transfection, and luciferase assay: All results about the promoter activity were provided using Caco2 cells. Caco2 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 1 mM sodium pyruvate, 0.1 mM mixture of nonessential amino acids, and 80 µg/ml gentamicin at 37°C in 5% CO 2 . Seven-tenths µg of target plasmids, 0.3 µg of Renilla luciferase vector phRL-TK (Promega), and 2 µl of Lipofectamine (Invitrogen) were mixed, and the total volume was adjusted to 100 µl by adding the medium. The plasmid solutions were incubated for 20 min at room temperature, and were added to the cells cultured in 24-well plates at a density of about 1.0 © 10 5 cells in 500 µl of medium/well. After incubation for 24 h, the medium was removed and the cells were washed with PBS (8.1 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 137 mM NaCl, 2.7 mM KCl, pH 7.4).
The cells were lysed using 100 µl of 100 mM K-phosphate buffer (pH 7.8) containing 0.5% Triton X-100, and the firefly luciferase and Renilla luciferase activities of 50 µl of lysate were assayed using the Dual-Luciferase Reporter Assay System (Promega). To verify the validity of this luciferase assay system, pGL3-control containing SV40 promoter and pGL3-basic containing no promoter were used as the positive and negative controls, respectively. Statistical analyses were performed using Student's t-test.
Results and Discussion
Activation of UGT1A9 proximal promoter by conversion into UGT1A8 sequence: The activities of UGT1A8 and 1A9 proximal promoters were examined in Caco2 cells, which is an in vitro model of the gastrointestinal tract. The results obtained from the cells might not necessarily correspond to the in vivo results, but at least we are able to understand the tendency of both promoters. Despite the high level of sequence similarity between the proximal UGT1A8 and 1A9 promoters (Fig. 1A) , the activity of the UGT1A8 promoter was shown to be about 5-fold higher than that of the equivalent UGT1A9 promoter in Caco2 cells (Fig. 1B) .
In the proximal promoter of UGT1A9, as shown in Figure 1A , the nucleotide sequence differs from that of UGT1A8 in three main regions, region 1 (upstream of the T-region), region 2 (around the T-region), and region 3 (Sp1/initiator-like region). To determine which differences are more critical for the promoter activity, the UGT1A9 promoter was converted into the UGT1A8 sequence. In the conversion of region 1, 4 bases (¹160T, ¹152T, ¹149G, and ¹137T) were replaced by the UGT1A8 sequence (C, A, A, and G, respectively). In the conversion of region 2, although the T-region was conserved as T 9 , 3 bases (¹130C, ¹113A, and ¹104A) were replaced by G, C, and T, and 2 nucleotides (T and G) were added between ¹128 and ¹127. In the conversion of region 3, 5 bases (¹72T, ¹71G, ¹67T, ¹62C, and ¹59A) were replaced by C, T, G, T and G.
As shown in Figure 1C , the conversion of region 3 had the greatest effect on the promoter activity. Gregory et al. reported that the mutation of this region decreased UGT1A8 promoter activity to background levels. 15) Our results showed that the UGT1A9 promoter activity increased up to about 60% of the UGT1A8 promoter with the conversion of this region to the UGT1A8 sequence. The difference in region 3 is, therefore, the main reason for the low activity of the UGT1A9 proximal promoter, but as shown in Figure 1C , the difference in region 1 is also likely to influence the activity somewhat. The conversions of both region 1 and region 3 brought increased activity compared with that solely by the conversion of region 3. Because the conversion of region 2 did not influence the activity, it is thought that the importance of the differences between the promoters is as follows: regions 3 > 1 > 2.
Then, to determine which differences in nucleotides in regions 1 and 3 of the UGT1A9 promoter lead to the low activity, many mutants converted to the UGT1A8 sequence were constructed by one base change. As shown in Table 1 , in region 3, the most important base changes were ¹62C and ¹59A, while three differences, ¹72T, ¹71G, and ¹67T, were not critical for the activity. The activity of the mutant having ¹62T and ¹59G was 49.9 « 5.0% compared with that with the UGT1A8 promoter, which was almost equal to the effect of the entire conversion of region 3 (Fig. 1C, r3) . In region 1, the most important base changes were ¹160T and ¹152T, and the relative activity of the mutant having Fig. 1 . Nucleotide sequences and the activities of UGT1A8 and 1A9 proximal promoters A: The proximal promoters of UGT1A8 (¹170 to +3) and 1A9 (¹164 to +3) are aligned from the initiation codon. The T-region is indicated by a shadow. Regions 1, 2, and 3 correspond to sections upstream of the T-region, around the T-region, and around the Sp1/initiator-like region in UGT1A9, respectively. Identical bases and missing bases are indicated with dashes and asterisks, respectively. The putative transcription factor binding sites are shown by bold lines, and the transcription start sites are marked with bold bases. 15) B: Luciferase activities of pGL1A8 and pGL1A9 having UGT promoters are shown as fold inductions over the promoterless pGL3-basic. The activity of pGL3-basic is set as 1. The relative activities are shown as mean « SD (n = 5). *p < 0.01 compared with the UGT1A9 promoter. C: Luciferase activities of pGL1A9 derivatives having the UGT1A9 promoter changed to the UGT1A8 sequence by region replacement are shown as fold induction over pGL1A8. The changes in region 1 (upstream of the T-region), region 2 (around the T-region), and region 3 (Sp1/initiator-like region) are indicated as r1, r2, and r3, respectively. r12, 13, 23, and 123 refer to mixed changes. The activity of pGL1A8 is set as 100%. The relative activities are shown as mean « SD (n = 5). *p < 0.01 compared with the UGT1A9 wild-type promoter. D: The number of T repeats in the UGT1A8 promoter was changed from 0 to 20. Luciferase activities of pGL1A8 derivatives are shown as fold induction over that of the wild type of pGL1A8 (T = 14). The activity of pGL1A8 (T = 14) is set as 100%. The relative activities are shown as mean « SD (n = 5). T 0-20 , UGT1A8 promoter having T repeats from 0 to 20; C 10 , UGT1A8 promoter having C repeats of 10. *p < 0.05 compared with the UGT1A8(T 8 ) promoter. 
a UGT1A9 wild type promoter; b Identical base is indicated with a dash; c Substitution points from UGT1A9 to 1A8 are shadowed; d The activity of UGT1A8 wild type promoter is set as 100% and the relative activities are shown as the mean « SD (n = 5); *p < 0.01 compared with the UGT1A9 wild type promoter; **p < 0.01 compared with the derivative UGT1A9 promoter having ¹62T and ¹59G.
¹160C and ¹152A added to ¹62T and ¹59G was 73.4 « 8.5%, which was close to the effect of the entire conversion of regions 1 + 3 and 1 + 2 + 3 (Fig. 1C, r13 and r123) . On the other hand, two differences, ¹149G and ¹137T, were not critical for the activity.
Influence of T-region on promoter activity and tissue-specific expression of UGT1A8 and 1A9: It was clarified that the activity of the UGT1A9 promoter increased up to about 80% of that of the UGT1A8 promoter with the conversion of regions 1+2+3, and this increase was almost completely brought about by only 4 base changes: ¹160C, ¹152A, ¹62T, and ¹59G. In the case of the conversion of regions 1+2+3 in the UGT1A9 designated UGT1A9-r123, the differences between the UGT1A8 and UGT1A9-r123 promoters were in the number of T repeats in the T-region, T 14 in UGT1A8 and T 9 in UGT1A9-r123, and the downstream sequence of region 3. Since all the differences in the section downstream of region 3 are located after the transcription start site, these differences hardly influence the promoter activity. Therefore, it is considered that the reason why the activity of UGT1A9-r123 did not recover to the UGT1A8 level was mainly the difference in the number of T repeats in the T-region.
From these considerations, the influence of the number of T repeats on the promoter activity was then examined in Caco2 cells. The number of T repeats in the UGT1A8 promoter was changed from 0 to 20. As shown in Figure 1D , when the T repeats were curtailed (T 8 and T 4 ), the promoter activity showed a tendency to decrease. However, when the T repeats were curtailed further (T 0 ) or were extended (T 16 and T 20 ), the activity was almost equal to that of the wild type, T 14 . Furthermore, when the T repeats were converted to C repeats (C 10 ), the activity was close to the value of the T 0 or T 20 . This result indicated that the nucleotide sequence of this region was not critical for the activity. From these results, it is thought that the T-region is not necessary for promoter activity, but the length of the T repeats influences the activity somewhat. It functions as a suppressor in T 8 and T 4 rather than as an activator for the promoter, and the important point for the function of the T-region may be not the nucleotide sequence but the number of nucleotides. In conclusion, it is likely that (i) the T-region and its surrounding area act as a spacer, and the length of this spacer regulates the construction of the network formed by the transcription factors binding before (region 1) and behind (region 3) it, and (ii) the cause of low activity of the UGT1A9 proximal promoter is not only 4 base changes, ¹160T, ¹152T, ¹62C, and ¹59A, but also the truncation of T repeats and a two-base deletion corresponding to ¹133T and ¹132G in the UGT1A8 promoter, which are just upstream of the T-region.
UGT1A7-10 promoters are highly homologous to each other. UGT1A7 and 1A9 have relatively short T repeats in the T-region (T 9 ), but only UGT1A9 is expressed in the liver. UGT1A8 having T 14 and UGT1A10 having T 15 are mainly expressed in extrahepatic cells. Although UGT1A7 having T 9 is also expressed in extra-hepatic cells, in the case of UGT1A7, its T-region probably functions as T 12 because of the additional 3 nucleotides around the T-region. Therefore, we assume that the UGT1A9 proximal promoter is derived from an original promoter having T 14 or T 15 working in the extra-hepatic cells, and it has evolved to lose the activity by critical base changes, the truncation of T repeats, and a two-base deletion just upstream of it. Instead of the proximal promoter, a new distal promoter that functions in hepatic cells might be formed. The expression of UGT1A9 is regulated by HNF1¡ and 4¡ which are expressed at the highest levels in the liver. [7] [8] [9] [10] 16) Therefore, HNF1¡ and HNF4¡ might function as activation factors for the distal promoter in hepatic cells. The suppression of the UGT1A8 proximal promoter in hepatic cells is unclear. Since this promoter is activated by HNF1¡ and Cdx2, 6) this activation process might be interfered with by other regulatory factors. Although more studies are necessary to clarify the tissuespecific expression of UGT1A7-10, T repeats may influence the promoter activity to some extent.
